New registrations
THE Therapeutic Goods Administration (TGA) has posted a new chemical entity (NCE) registration and two ‘extension of indication’ registrations for Apr on its website.
The NCE is Afstyla (lonoctocog alfa [recombinant single-chain coagulation factor VIII]) vy CSL Behring Australia for haemophilia.
Extensions of indication were granted for AbbVie’s Viekira Pak-RBV (paritaprevir/ritonavir/ ombitasvir & dasabuvir & ribavirin) and Viekera Pak (paritaprevir/ ritonavir/ombitasvir & dasabuvir) for hepatitis C treatments.